The purpose of this blinded, multi-center, prospective, case-controlled study is to compare the Ariosa Harmony™ Prenatal Test for trisomy 21 detection with a standard first-trimester prenatal screening test consisting of serum screening (PAPP-A,free beta-hCG \[β-hCG\] or total hCG) and a nuchal translucency (NT) measurement (i.e. combined first trimester screening) in a general screened population. The performance characteristics of these two test modalities will be assessed relative to the clinical reference standard of genetic analysis of the fetus or phenotypic characterization and genetic analysis of the newborn.
Study Type
OBSERVATIONAL
Enrollment
18,955
Difference in sensitivity and specificity of Ariosa Harmony™ Prenatal Test (AUCt) and combined first-trimester screening for detection of T21.
Time frame: Enrollment to delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tucson Medical Center
Tucson, Arizona, United States
East Bay Perinatal Associates
Oakland, California, United States
Stanford University
Palo Alto, California, United States
Perinatal Diagnostic Center
Riverside, California, United States
University of California San Diego
San Diego, California, United States
California Pacific Medical Center
San Francisco, California, United States
University of California San Francisco
San Francisco, California, United States
The Institute of Prenatal Diagnosis and Reproductive Medicine
San Gabriel, California, United States
Christiana Care Health System
Newark, Delaware, United States
Altus Research
Lake Worth, Florida, United States
...and 26 more locations